BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 3646827)

  • 1. Raised fecal fat concentration is not a valid indicator of pancreatic steatorrhea.
    Lembcke B; Grimm K; Lankisch PG
    Am J Gastroenterol; 1987 Jun; 82(6):526-31. PubMed ID: 3646827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal fat concentration in the differential diagnosis of steatorrhea.
    Bai JC; Andrüsh A; Matelo G; Martinez C; Vazquez H; Boerr L; Sambuelli A
    Am J Gastroenterol; 1989 Jan; 84(1):27-30. PubMed ID: 2912027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal fat concentration in patients with steatorrhea.
    Bo-Linn GW; Fordtran JS
    Gastroenterology; 1984 Aug; 87(2):319-22. PubMed ID: 6735076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of fecal fat concentrations as screening test in pancreatic insufficiency.
    Roberts IM; Poturich C; Wald A
    Dig Dis Sci; 1986 Oct; 31(10):1021-4. PubMed ID: 3757718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency.
    Gaskin KJ; Durie PR; Lee L; Hill R; Forstner GG
    Gastroenterology; 1984 Jan; 86(1):1-7. PubMed ID: 6689652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid steatocrit determination is not helpful in cystic fibrosis patients without or with mild steatorrhea.
    Walkowiak J; Lisowska A; Blask-Osipa A; Drzymała-Czyz S; Sobkowiak P; Cichy W; Breborowicz A; Herzig KH; Radzikowski A
    Pediatr Pulmonol; 2010 Mar; 45(3):249-54. PubMed ID: 20146370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
    Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
    Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
    Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus.
    Hahn JU; Kerner W; Maisonneuve P; Lowenfels AB; Lankisch PG
    Pancreas; 2008 Apr; 36(3):274-8. PubMed ID: 18362841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rationalization of the quantitative determination of fecal fat].
    Bornschein W; Lessner F
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(6):333-42. PubMed ID: 4092655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic exocrine hypofunction in the wasting syndrome of end-stage renal disease.
    Sachs EF; Hurwitz FJ; Bloch HM; Milne FJ
    Am J Gastroenterol; 1983 Mar; 78(3):170-3. PubMed ID: 6829538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid steatocrit: a simple, rapid gravimetric method to determine steatorrhea.
    Amann ST; Josephson SA; Toskes PP
    Am J Gastroenterol; 1997 Dec; 92(12):2280-4. PubMed ID: 9399770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and significance of steatorrhea in patients with active Graves' disease.
    Goswami R; Tandon RK; Dudha A; Kochupillai N
    Am J Gastroenterol; 1998 Jul; 93(7):1122-5. PubMed ID: 9672342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitamin A absorption test. I. Pancreatic insufficiency and sprue (author's transl)].
    Schmidt G; Schröder G; Eisenberg K
    Med Klin; 1975 Oct; 70(43):1745-50. PubMed ID: 1186578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis, diagnosis and therapy of steatorrhea].
    Berndt H
    Dtsch Gesundheitsw; 1969 Jun; 24(26):1201-8. PubMed ID: 4913159
    [No Abstract]   [Full Text] [Related]  

  • 18. Faecal elastase-I: helpful in analysing steatorrhoea?
    Symersky T; van der Zon A; Biemond I; Masclee AA
    Neth J Med; 2004 Sep; 62(8):286-9. PubMed ID: 15588069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal alpha 1-antitrypsin clearance in the differential diagnosis of steatorrhea.
    Bai JC; Sugai E; Morán C; Sambuelli A; Vázquez H; Mazure R; Boerr L; Mackenzie D
    Acta Gastroenterol Latinoam; 1992; 22(2):95-8. PubMed ID: 1300854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath tests.
    Watkins JB; Klein PD; Schoeller DA; Kirschner BS; Park R; Perman JA
    Gastroenterology; 1982 May; 82(5 Pt 1):911-7. PubMed ID: 7060913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.